Mesalamine Capsule, Extended Release
Product Images NDC 0093-9224

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0093-9224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Mesalamine Extended-Release Capsules are a prescription medication used to treat various bowel diseases. Each capsule contains 0.375g of mesalamine. The product should be stored between 20°C to 25°C (68°F to 77°F) and should be kept out of reach of children. The usual dosage of the medication can be found in the package insert for full prescribing information. The medication is distributed by Teva Pharmaceuticals USA, inc. with a total of 120 capsules in the package. It should be noted that phenylketonurics should be aware that these capsules contain phenylalanine. Information about the patent can be found in the package insert.*

FDA Label Image

Image 02

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.